Pneumocystis carinii Pneumonia in a 3-Month-Old Infant Receiving High-Dose Corticosteroid Therapy for Airway Hemangiomas

Roger Aviles, Thomas G. Boyce*, Dana M. Thompson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Primary infection with Pneumocystis carinii usually occurs early in life, and young infants receiving prolonged treatment with high-dose corticosteroids may be at risk for the development of symptomatic disease. Prophylaxis with trimethoprim-sulfamethoxazole is safe and effective and should be considered for such infants, particularly those with underlying airway abnormalities. We describe a 3-month-old immunocompetent infant who developed severe P carinii pneumonia after 6 weeks of high-dose corticosteroid therapy for cervicofacial and airway hemangiomas.

Original languageEnglish (US)
Pages (from-to)243-245
Number of pages3
JournalMayo Clinic Proceedings
Volume79
Issue number2
DOIs
StatePublished - Feb 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pneumocystis carinii Pneumonia in a 3-Month-Old Infant Receiving High-Dose Corticosteroid Therapy for Airway Hemangiomas'. Together they form a unique fingerprint.

Cite this